Clinical Trials Directory

Trials / Completed

CompletedNCT00533208

MK0524 Seasonal Allergic Rhinitis Study (0524-005)(COMPLETED)

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
766 (actual)
Sponsor
Merck Sharp & Dohme LLC · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

To assess the efficacy of MK0524 on seasonal allergies.

Conditions

Interventions

TypeNameDescription
DRUGMK0524

Timeline

Start date
2003-07-01
Primary completion
2003-10-01
Completion
2003-10-01
First posted
2007-09-21
Last updated
2015-12-22

Source: ClinicalTrials.gov record NCT00533208. Inclusion in this directory is not an endorsement.